Skip to content

Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm

Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04214782
Enrollment
10000
Registered
2020-01-02
Start date
2022-10-01
Completion date
2024-10-01
Last updated
2021-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Brief summary

Ovarian cancer is relatively rare but fatal with an annual incidence rate of 11.8 per 100 000 and a high mortality-to-incidence ratio of \>0.6. The modest diagnostic accuracy of TVU has risen some concerns about the over-treatment.Now, with the development of artificial intelligence (AI), we may have a better chance to interpret TVU imagines with high efficiency, reproducibility and accuracy.

Interventions

DIAGNOSTIC_TESTArtificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm

AI Enabled Transvaginal Ultrasound diagnosis for ovarian cancer

Sponsors

Hubei Cancer Hospital
CollaboratorOTHER
Qilu Hospital of Shandong University
CollaboratorOTHER
Henan Cancer Hospital
CollaboratorOTHER_GOV
Xiangyang Central Hospital
CollaboratorOTHER
The First People's Hospital of Jingzhou
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Women scheduled for Transvaginal Ultrasound examination for adnexal lesions; * Women aged over 18 years old; * Women willing to participant in this study evidenced by signing the informed consent.

Exclusion criteria

* Women without adnexa for any reasons at the time of Transvaginal Ultrasound examination, including but not limited to receiving surgical removal for adnexa; * Women with a pathologic diagnosis of ovarian cancer before the Transvaginal Ultrasound examination; * Women with mental abnormal; * Women did not cooperate or participate in other clinical trials; * Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
diagnostic accuracy2 yearsdiagnostic accuracy comparison between Transvaginal Ultrasound diagnosis with and without Artificial Intelligence algorithm for ovarian cancer

Secondary

MeasureTime frameDescription
time cost for Transvaginal Ultrasound image interpretation2 yearstime cost for radiologists to interpret Transvaginal Ultrasound images

Contacts

Primary ContactQinglei Gao, MD, PhD
qingleigao@hotmail.com13871127473
Backup ContactDing Ma, MD, PhD
dingma424@126.com13886090620

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026